# The Radiofrequency Therapy in Management of Sickle Cell Disease Chronic Pain RCT Tested the Effect of TECAR Therapy on Sickle Cell Disease Chronic Pain.

> **NCT07066072** · NA · COMPLETED · sponsor: **Cairo University** · enrollment: 170 (actual)

## Conditions studied

- the Use of Radiofrequency Ablation in Form of TECAR(Capacitive and Resistive Transfer Energy) in Chronic Pain of Sickle Cell Disease Patients

## Interventions

- **DEVICE:** Tecar therapy (TECAR: Capacitive and Resistive Energy Transfer).
- **OTHER:** standard pharmacological therapy in sickle cell disease like hydroxyurea,paracetamol,ibubrofen and blood transfusion if needed

## Key facts

- **NCT ID:** NCT07066072
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-03-30
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2025-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07066072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07066072, "The Radiofrequency Therapy in Management of Sickle Cell Disease Chronic Pain RCT Tested the Effect of TECAR Therapy on Sickle Cell Disease Chronic Pain.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07066072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*